{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:50:01Z","timestamp":1778622601880,"version":"3.51.4"},"reference-count":17,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,4]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>A reciprocal t(3;8) BCL6::MYC fusion is common in large B-cell lymphoma (LBCL) with MYC and BCL6 disruption. These pseudo\u2013double-hit cases are not adverse, whereas t(3;8)\u2212MYC\/BCL6 lymphoma has an inferior prognosis relative to other MYC-rearranged LBCL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2024024048","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T19:54:30Z","timestamp":1713815670000},"page":"113-117","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Testing for t(3;8) in MYC\/BCL6-rearranged large B-cell lymphoma identifies a high-risk subgroup with inferior survival"],"prefix":"10.1182","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7064-8900","authenticated-orcid":false,"given":"Bernard D.","family":"Maybury","sequence":"first","affiliation":[{"name":"1Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"James","sequence":"additional","affiliation":[{"name":"2Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Phillips","sequence":"additional","affiliation":[{"name":"3Department of Haematology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indrani","family":"Venkatadasari","sequence":"additional","affiliation":[{"name":"4Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman","family":"Qureshi","sequence":"additional","affiliation":[{"name":"5Department of Haematology, Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Riley","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Talbot","sequence":"additional","affiliation":[{"name":"3Department of Haematology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7639-4008","authenticated-orcid":false,"given":"Shivir","family":"Moosai","sequence":"additional","affiliation":[{"name":"6Department of Haematology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom"},{"name":"7Department of Haematology, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Giles","sequence":"additional","affiliation":[{"name":"3Department of Haematology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Chadderton","sequence":"additional","affiliation":[{"name":"2Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Dowds","sequence":"additional","affiliation":[{"name":"2Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallav","family":"Rakesh","sequence":"additional","affiliation":[{"name":"8Department of Haematology, The Dudley Group NHS Foundation Trust, Dudley, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Crosland","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan","family":"Haslam","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Lane","sequence":"additional","affiliation":[{"name":"9Department of Haematology, Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Vega Gonzalez","sequence":"additional","affiliation":[{"name":"10Department of Haematology, Walsall Healthcare NHS Trust, Walsall, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Davies","sequence":"additional","affiliation":[{"name":"6Department of Haematology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Cherian","sequence":"additional","affiliation":[{"name":"9Department of Haematology, Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Shenouda","sequence":"additional","affiliation":[{"name":"8Department of Haematology, The Dudley Group NHS Foundation Trust, Dudley, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Kaudlay","sequence":"additional","affiliation":[{"name":"4Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Starczynski","sequence":"additional","affiliation":[{"name":"2Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-2115","authenticated-orcid":false,"given":"Zbigniew","family":"Rudzki","sequence":"additional","affiliation":[{"name":"2Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar","family":"Chaganti","sequence":"additional","affiliation":[{"name":"1Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"22","key":"2024070415202583200_bib1","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","article-title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"issue":"35","key":"2024070415202583200_bib2","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1200\/JCO.19.00743","article-title":"Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the Lunenburg lymphoma biomarker consortium","volume":"37","author":"Rosenwald","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"2024070415202583200_bib3","first-page":"530","article-title":"BCL6 rearrangement indicates poor prognosis in diffuse large B-cell lymphoma patients: a meta-analysis of cohort studies","volume":"10","author":"Li","year":"2019","journal-title":"J\u00a0Cancer"},{"issue":"1","key":"2024070415202583200_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41408-023-00827-5","article-title":"A\u00a0retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the\u00a0new WHO and ICC classifications","volume":"13","author":"El-Sharkawi","year":"2023","journal-title":"Blood Cancer J"},{"issue":"suppl 1","key":"2024070415202583200_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood-2023-190316","article-title":"Comparing clinical characteristics and outcomes of MYC and BCL6 double hit lymphoma (DHL- BCL6) with other aggressive B-cell lymphomas: understanding the impact of new WHO and International Consensus Classifications [abstract]","volume":"142","author":"Khurana","year":"2023","journal-title":"Blood"},{"issue":"7","key":"2024070415202583200_bib6","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"2024070415202583200_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2024070415202583200_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cancergencyto.2005.12.013","article-title":"A\u00a0subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma\/leukemia and ataxia-telangiectasia","volume":"168","author":"Sandlund","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"issue":"20","key":"2024070415202583200_bib9","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/bloodadvances.2018023572","article-title":"High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology","volume":"2","author":"Chong","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"2024070415202583200_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41375-023-02134-1","article-title":"Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential","volume":"38","author":"Zhang","year":"2024","journal-title":"Leukemia"},{"issue":"10","key":"2024070415202583200_bib11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1158\/2159-8290.CD-15-0370","article-title":"Detection of enhancer-associated rearrangements reveals mechanisms of oncogene dysregulation in B-cell lymphoma","volume":"5","author":"Ryan","year":"2015","journal-title":"Cancer Discov"},{"issue":"6","key":"2024070415202583200_bib12","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1038\/bcj.2017.59","article-title":"Cryptic t(3;8)(q27;q24) and\/or MYC-BCL6 linkage associated with MYC expression by immunohistochemistry is frequent in multiple-hit B-cell lymphomas","volume":"7","author":"Ohno","year":"2017","journal-title":"Blood Cancer J"},{"issue":"4","key":"2024070415202583200_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A\u00a0probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"21","key":"2024070415202583200_bib14","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1200\/JCO.18.01994","article-title":"Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: clinical outcomes of the phase III Intergroup Trial Alliance\/CALGB 50303","volume":"37","author":"Bartlett","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2024070415202583200_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bjh.14136","article-title":"Guidelines for the management of diffuse large B-cell lymphoma","volume":"174","author":"Chaganti","year":"2016","journal-title":"Br J Haematol"},{"issue":"9","key":"2024070415202583200_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.annonc.2020.05.016","article-title":"Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M\/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial","volume":"31","author":"McMillan","year":"2020","journal-title":"Ann Oncol"},{"key":"2024070415202583200_bib17","doi-asserted-by":"crossref","first-page":"102513","DOI":"10.1016\/j.canep.2023.102513","article-title":"Lymphoid blood cancers, incidence and survival 2005-2023: a report from the UK\u2019s Haematological Malignancy Research Network","volume":"88","author":"Lamb","year":"2024","journal-title":"Cancer Epidemiol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/1\/113\/2233502\/blood_bld-2024-024048-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/1\/113\/2233502\/blood_bld-2024-024048-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T15:20:48Z","timestamp":1720106448000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/1\/113\/515828\/Testing-for-t-3-8-in-MYC-BCL6-rearranged-large-B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024024048","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]}}}